Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BNIP3P24 is a pseudogene related to the BCL2 interacting protein 3 (BNIP3) gene but does not produce a functional protein in humans. Pseudogenes like BNIP3P24 are typically non-functional genomic DNA sequences resembling known genes. While the BNIP gene family plays important roles in apoptosis and autophagy, with members like BNIP3 and BNIP3L acting as pro-apoptotic proteins, BNIP3P24 itself does not encode any functional protein and is not a therapeutic target. Consequently, it does not have biological functions, disease associations, or known drug interactions. Its designation as a pseudogene means it does not participate in cellular signaling or serve as a biomarker for disease. No evidence indicates BNIP3P24 is incorrectly labeled as a therapeutic target; rather, it fits the pattern of multiple identified BNIP3-related pseudogenes, which are generally functionally inert.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 24 (BNIP3P24).